AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

3.480

+0.0200.58%

Volume:1.54M

Turnover:5.34M

Market Cap:2.09B

PE:-10.17

High:3.500

Open:3.420

Low:3.400

Close:3.460

52wk High:7.550

52wk Low:1.400

Shares:601.57M

Float Shares:377.76M

Volume Ratio:0.43

T/O Rate:0.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.342

EPS(LYR):-0.342

ROE:-174.43%

ROA:-15.62%

PB:12.30

PE(LYR):-10.17

Loading ...

Overview Company News Filings

BRIEF-4Dmedical Launches Clear Clinical Evidence Program

4DMedical Ltd - Launches Clear Clinical Evidence Program Designed to Fast-Track Ct:Vq™ Entry Into Acute Pulmonary Embolism (Pe) Market

THOMSON REUTERS

Does 4DMedical’s (ASX:4DX) CT:VQ Clinical Focus Reframe Its Technology Adoption and Earnings Story?

Simply Wall St.

BRIEF-4Dmedical Creates EU Platform Via Contextflow Acquisition

BUZZ-Australia's 4DMedical rises on establishing European platform via acquisition

4DMedical to Acquire Austrian Medical AI Company Contextflow in Cash, Stock Deal; Shares Up 6%

MT Newswires Live

Stock Track | 4DMedical Soars 5.79% Intraday on CT:VQ Clinical Call and European Expansion via Contextflow Acquisition

4DMedical - Establishes European Commercial and Clinical Platform

THOMSON REUTERS

4DMedical - Signs Agreement to Buy Contextflow for European Expansion

THOMSON REUTERS

4DMedical Ltd-4DMedical Creates EU Platform via Contextflow Acquisition

THOMSON REUTERS

4DMedical - Acquisition Terms Include a$18.56 Mln Cash, 56,235 Shares, up to 2.59 Mln Options

THOMSON REUTERS

Assessing 4DMedical's Valuation As CT:VQ Clinical Use Call Draws Fresh Attention

Simply Wall St.

ASX Biggest Gainers

MT Newswires Live

4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%

MT Newswires Live

Stock Track | 4DMedical Soars 8.08% Intraday on US Outpatient Market Expansion Through Simonmed's Network

4DMedical Ltd - Ct:Vq Enters US Outpatient Market via Simonmed's 170-Site Network

THOMSON REUTERS

Is 4DMedical’s (ASX:4DX) CT:VQ Push Reframing Its Edge In Respiratory Imaging Adoption?

Simply Wall St.

Stock Track | 4DMedical Soars 8.00% Intraday on Positive Study Results for CT:VQ Imaging Product

4DMedical Says Study Shows CT:VQ Imaging Product Lifts Lung Surgery Response Rate to 76%; Shares Up 3%

MT Newswires Live

Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/4DX.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":3.48,"timestamp":1789020720000,"preClose":3.46,"halted":0,"volume":1543114,"delay":0,"changeRate":0.0057803468208092535,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":601571602,"eps":-0.342118,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"09-10 16:12:00 AEST","open":3.42,"high":3.5,"low":3.4,"amount":5339171,"amplitude":0.028902,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.342118,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.46,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":0.42943181102065403,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"4DX.AU","preClose":3.46,"auctionPrice":3.49,"auctionVolume":139813,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020603559}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-15.62%","roe":"-174.43%","lyrEps":-0.342118,"volumeRatio":0.42943181102065403,"shares":601571602,"dividePrice":0,"high":3.5,"amplitude":0.028902,"preClose":3.46,"low":3.4,"week52Low":1.4,"pbRate":"12.30","psRate":"296.46","week52High":7.55,"institutionHeld":0,"latestPrice":3.48,"eps":-0.342118,"divideRate":0,"volume":1543114,"delay":0,"ttmEps":-0.342118,"open":3.42,"prevYearClose":3.93,"prevWeekClose":3.6,"prevMonthClose":3.42,"prevQuarterClose":4.53,"fiveDayClose":3.44,"twentyDayClose":3.91,"sixtyDayClose":3.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640998634","title":"BRIEF-4Dmedical Launches Clear Clinical Evidence Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2640998634","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640998634?lang=en_us&edition=fundamental","pubTime":"2026-06-02 07:52","pubTimestamp":1780357972,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmedical Launches Clear Clinical Evidence ProgramJune 2 (Reuters) - 4DMedical Ltd 4DX.AX:LAUNCHES CLEAR CLINICAL EVIDENCE PROGRAM DESIGNED TO FAST-TRACK CT:VQ™ ENTRY INTO ACUTE PULMONARY EMBOLISM (PE) MARKETFurther company coverage: 4DX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640960526","title":"4DMedical Ltd - Launches Clear Clinical Evidence Program Designed to Fast-Track Ct:Vq™ Entry Into Acute Pulmonary Embolism (Pe) Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2640960526","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640960526?lang=en_us&edition=fundamental","pubTime":"2026-06-02 06:31","pubTimestamp":1780353067,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640685879","title":"Does 4DMedical’s (ASX:4DX) CT:VQ Clinical Focus Reframe Its Technology Adoption and Earnings Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2640685879","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640685879?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:21","pubTimestamp":1780323691,"startTime":"0","endTime":"0","summary":"In May 2026, 4DMedical held a special call to present on the clinical use of its CT:VQ technology, highlighting how the platform may be applied in real-world respiratory imaging. \nThis focused discussion on CT:VQ’s clinical role adds fresh context to earlier expectations that the technology could open access to a large VQ imaging market. \nWe’ll now examine how this CT:VQ clinical-use call may influence 4DMedical’s investment narrative built around technology adoption and earnings...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/does-4dmedicals-asx4dx-ctvq-clinical-focus-reframe-its-techn","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/does-4dmedicals-asx4dx-ctvq-clinical-focus-reframe-its-techn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640981707","title":"BRIEF-4Dmedical Creates EU Platform Via Contextflow Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2640981707","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640981707?lang=en_us&edition=fundamental","pubTime":"2026-06-01 09:03","pubTimestamp":1780275828,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmedical Creates EU Platform Via Contextflow AcquisitionJune 1 (Reuters) - 4DMedical Ltd 4DX.AX:4DMEDICAL CREATES EU PLATFORM VIA CONTEXTFLOW ACQUISITIONESTABLISHES EUROPEAN COMMERCIAL AND CLIN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUENYJK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640811089","title":"BUZZ-Australia's 4DMedical rises on establishing European platform via acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2640811089","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640811089?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:43","pubTimestamp":1780274598,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's 4DMedical rises on establishing European platform via acquisition** Shares of 4DMedical 4DX.AX rise as much as 7.8% to A$4.28, their highest level since May 19** The medtech firm establishes an immediate European commercial and clinical platform, expanding operations to a third major region alongside North America and ANZ** Expansion accelerated via binding agreement to buy Austrian-based contextflow GmbH, a medical technology firm specialising in lung cancer screening, advanced AI-driven thoracic imaging, adds company** Acquisition agreed on heavily discounted terms including upfront payments of A$18.56 million  in cash, others** Stock up 6.4% this year, including the day's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL4N429018:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7135","4DX.AU","ANZ.AU","BK7094","AN3PL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640819029","title":"4DMedical to Acquire Austrian Medical AI Company Contextflow in Cash, Stock Deal; Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640819029","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640819029?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:38","pubTimestamp":1780274327,"startTime":"0","endTime":"0","summary":"4DMedical  signed a binding agreement to acquire Austria-based contextflow, a medical technology company specializing in lung cancer screening and advanced artificial intelligence-driven thoracic imaging, in a deal that includes upfront cash payments of about AU$18.6 million, according to a Monday Australian bourse filing.The deal also includes 56,235 ordinary shares, plus an earn-out of up to 2.6 million zero-exercise-price options over two years subject to performance milestonesThe company said the acquisition establishes an immediate European commercial and clinical platform, with contextflow retaining about AU$30.8 million in accumulated tax losses.The acquisition introduces insurance reimbursement contracts in Germany and helps expand the company's CT:VQ product across the region, per the filing.4DMedical's shares jumped nearly 6% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIX","4DX.AU","AIPO","ARTY","BK7094","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131606859","title":"Stock Track | 4DMedical Soars 5.79% Intraday on CT:VQ Clinical Call and European Expansion via Contextflow Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=1131606859","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131606859?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:02","pubTimestamp":1780272164,"startTime":"0","endTime":"0","summary":"4DMedical Ltd (ASX:4DX) saw its stock price soar 5.79% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.The sharp price increase...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640989968","title":"4DMedical - Establishes European Commercial and Clinical Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2640989968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640989968?lang=en_us&edition=fundamental","pubTime":"2026-06-01 07:32","pubTimestamp":1780270322,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nTUENYJK0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640989966","title":"4DMedical - Signs Agreement to Buy Contextflow for European Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2640989966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640989966?lang=en_us&edition=fundamental","pubTime":"2026-06-01 07:32","pubTimestamp":1780270322,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nTUENYJK0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640989963","title":"4DMedical Ltd-4DMedical Creates EU Platform via Contextflow Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2640989963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640989963?lang=en_us&edition=fundamental","pubTime":"2026-06-01 07:32","pubTimestamp":1780270322,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nTUENYJK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640899509","title":"4DMedical - Acquisition Terms Include a$18.56 Mln Cash, 56,235 Shares, up to 2.59 Mln Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2640899509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640899509?lang=en_us&edition=fundamental","pubTime":"2026-06-01 07:32","pubTimestamp":1780270322,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nTUENYJK0:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639715988","title":"Assessing 4DMedical's Valuation As CT:VQ Clinical Use Call Draws Fresh Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2639715988","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639715988?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:08","pubTimestamp":1780232909,"startTime":"0","endTime":"0","summary":"4DMedical special call puts CT:VQ clinical use in focus\n4DMedical (ASX:4DX) is drawing fresh attention after scheduling a special call to present on the clinical use of its CT:VQ non contrast post processing technology, spotlighting how this lung imaging software might fit into everyday healthcare workflows.\nSee our latest analysis for 4DMedical.\nThe A$3.97 share price has moved sharply around this news, with an 18.86% 1 day share price return and 9.67% 7 day share price return, in contrast...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-as-ctvq-clinical-use-call-dra","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-as-ctvq-clinical-use-call-dra","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639432006","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639432006","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639432006?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:55","pubTimestamp":1780023344,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest gains on Friday.Electro Optic Systems : +15%, AU$11Elsight : +13%, AU$7.184DMedical : +12%, AU$3.74Judocapitol FP : +11%, AU$1.54Flight Centre Travel Group : +8%, AU$10.96West African Resources : +8%, AU$3.19Lindian Resources : +8%, AU$0.83Ora Banda Mining : +7%, AU$1.36Vulcan Energy Resources : +7%, AU$3.89Westgold Resources : +6%, AU$5.18","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7504","BK7506","EOS.AU","WGX.AU","BK7135","OBM.AU","BK7115","BK7070","ELS.AU","BK7095","FLT.AU","VUL.AU","BK7094","JDO.AU","WAF.AU","BK7084","4DX.AU","LIN.AU","BK7104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648374","title":"4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648374","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639648374?lang=en_us&edition=fundamental","pubTime":"2026-05-29 09:40","pubTimestamp":1780018807,"startTime":"0","endTime":"0","summary":"4DMedical  struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.\"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity,\" the company said.The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.4DMedical shares surged 11% in recent Friday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189474019","title":"Stock Track | 4DMedical Soars 8.08% Intraday on US Outpatient Market Expansion Through Simonmed's Network","url":"https://stock-news.laohu8.com/highlight/detail?id=1189474019","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189474019?lang=en_us&edition=fundamental","pubTime":"2026-05-29 08:16","pubTimestamp":1780013785,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's stock soared 8.08% during intraday trading on Friday, following the company's announcement of a significant market expansion.The medical technology company has entered the US...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639612102","title":"4DMedical Ltd - Ct:Vq Enters US Outpatient Market via Simonmed's 170-Site Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2639612102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639612102?lang=en_us&edition=fundamental","pubTime":"2026-05-29 08:04","pubTimestamp":1780013055,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4250WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637730351","title":"Is 4DMedical’s (ASX:4DX) CT:VQ Push Reframing Its Edge In Respiratory Imaging Adoption?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637730351","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637730351?lang=en_us&edition=fundamental","pubTime":"2026-05-24 17:18","pubTimestamp":1779614323,"startTime":"0","endTime":"0","summary":"Earlier this month, 4DMedical Limited presented on the clinical use of its CT:VQ technology, highlighting its advanced respiratory imaging capabilities and potential role alongside existing lung function assessments.\nThis focus on real-world clinical application offers investors a clearer view of how 4DMedical’s CT:VQ platform could fit into everyday hospital workflows and diagnostic decision-making.\nWe’ll now examine how this emphasis on CT:VQ’s clinical use may influence 4DMedical’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-ctvq-push-reframing-its-edge-in-respira","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-ctvq-push-reframing-its-edge-in-respira","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188640825","title":"Stock Track | 4DMedical Soars 8.00% Intraday on Positive Study Results for CT:VQ Imaging Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1188640825","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188640825?lang=en_us&edition=fundamental","pubTime":"2026-05-19 08:40","pubTimestamp":1779151230,"startTime":"0","endTime":"0","summary":"4DMEDICAL LTD (ASX:4DX) saw its shares soar 8.00% during intraday trading on Tuesday, following the announcement of positive clinical study results.The surge comes after the company disclosed that a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636400005","title":"4DMedical Says Study Shows CT:VQ Imaging Product Lifts Lung Surgery Response Rate to 76%; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636400005","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636400005?lang=en_us&edition=fundamental","pubTime":"2026-05-19 08:37","pubTimestamp":1779151030,"startTime":"0","endTime":"0","summary":"4DMedical  said a study evaluating its CT:VQ imaging product, published in the American Journal of Respiratory and Critical Care Medicine, shows that CT:VQ-guided patient selection would deliver a 76% response rate to lung volume reduction surgery , compared with the current rate of 46%, according to a Tuesday Australian bourse filing.The company said CT:VQ derives functional ventilation and perfusion information from existing non-contrast CT scans, with improved pre-operative patient selection strengthening the economics of LVRS programs for hospitals by concentrating surgical resources on patients most likely to benefit.The company's shares were up 3% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635065547","title":"Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2635065547","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635065547?lang=en_us&edition=fundamental","pubTime":"2026-05-16 19:40","pubTimestamp":1778931634,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) is back in focus after securing a one year contract with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development, while its respiratory imaging technologies draw heightened investor attention.\nSee our latest analysis for 4DMedical.\nThe GSK contract has arrived at a time when momentum around the stock is shifting again, with the share price up 8.88% in the last day and 29.91% over the week, but down 34.12% over 30 days, while very large...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GSK.UK","BK4585","GSK","LU1829250122.USD","BK4532","4DX.AU","BK4007","BK7094","BK4588","GSKH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":98,"code":"91000000","status":"200"}]}}